Donggu BioPharm Decides to Enter into a Trust Contract for Acquisition of Treasury Shares Worth 2 Billion KRW

[Asia Economy Reporter Minji Lee] Donggu Bio Pharmaceutical announced on the 14th that it has decided to enter into a trust contract with NH Investment & Securities for the acquisition of its own shares worth 2 billion KRW. The company stated, "This is to stabilize the stock price and enhance shareholder value."